Finanzwire Finanzwire
Basculer en Français
9472 Companies
185369 Keywords
117719 Articles
99261 Press releases
Headlines Articles Press releases NeuroSync Laboratories Remove
  1. Home
  2. Companies
  3. NeuroSync Laboratories
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/26/2024 at 18:00, 1 year 9 months ago

    NeuroSync Labs revolutionizes the VR experience with a solution for motion sickness

    Innovation NeuroSync Labs C-Infinity Virtual Reality Travel Sickness
  • PRESS RELEASE

    published on 02/26/2024 at 18:00, 1 year 9 months ago

    NeuroSync Laboratories Publishes Peer-Reviewed Scientific Research Paper Demonstrating Anti-Nausea Effect of C-Infinity

    NeuroSync Labs' groundbreaking research on mitigating motion sickness in virtual reality (VR) published in Neuroscience Letters highlights the use of C-Infinity controller for immersive and nausea-free VR experiences
    NeuroSync Labs Virtual Reality Motion Sickness C-Infinity Controller VR Technology
    Logo of NeuroSync Laboratories
  • PRESS RELEASE

    published on 01/23/2024 at 16:00, 1 year 10 months ago

    NeuroSync Laboratories Unveils Revolutionary VR Gaming Experience With C-Infinity

    NeuroSync Labs announced the launch of its groundbreaking product C-Infinity on Kickstarter. This 21st-century neuro-digital interface revolutionizes VR gaming, offering an immersive and nausea-free experience. The C-Infinity, resembling an upright standing VR simulator, provides true locomotion and a direct brain-to-machine interface, setting new standards for virtual interaction. Backers can now avail a limited-time discount of over 60% on Kickstarter on January 23. For more information about NeuroSync Labs or C-Infinity, please visit https://neurosyncvr.com.
    NeuroSync Labs C-Infinity VR Gaming Virtual Reality Kickstarter Discount
    Logo of NeuroSync Laboratories
Accesswire
  • Published on 12/05/2025 at 02:35, 1 hour 54 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 1 hour 59 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 3 hours 29 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 5 hours 24 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 5 hours 29 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 03:30, 59 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 4 hours 38 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 8 hours 4 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 8 hours 14 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

  • Published on 12/04/2025 at 19:10, 9 hours 19 minutes ago

    SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:00, 10 hours 29 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 10 hours 44 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 12/04/2025 at 17:44, 10 hours 45 minutes ago

    Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

  • Published on 12/04/2025 at 07:01, 21 hours 28 minutes ago

    bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

  • Published on 12/03/2025 at 18:00, 1 day 10 hours ago

    Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2025 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy